ArticleBiomedical engineering advances2024
Multiphoton imaging for quantification of mesenchymal stem cell survival and distribution in PEG granular hydrogel scaffolds post-implantation into rat cranial bone defects.
Article in Biomedical engineering advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mesenchymal stem cells (MSCs) are promising candidates for cellular therapies aimed at promoting bone regeneration due to their secretory properties and osteoblastic differentiation capacity. However, typically < 5% of delivered MSCs are retained at the healing site within days of delivery via injection. In this work, granular PEG hydrogel scaffolds were used to deliver MSCs, labeled with fluorescent Quantum Dots, into critical-sized rat calvarial bone defects. The presence, survival, and distribution of MSCs within the hydrogel scaffold were evaluated with multiphoton microscopy at 3- and 7-days post-implantation. Additionally, endogenous cell infiltration into scaffolds was quantified, and markers for M1 and M2 macrophages were identified with immunohistochemistry. This multiphoton microscopy technique provides a quantitative analysis of exogenous MSC presence and survival and allows for micron-level spatial resolution of cell distribution throughout the implanted scaffolds. When ~750,000 MSCs were implanted in a calvarial bone defect via PEG granular hydrogel scaffolds, ~27% and ~8% survived 3- and 7-days post-implantation, respectively. At 3- and 7-days post-implantation, exogenous MSCs and infiltrating endogenous cells, including M1 and M2 macrophages, were well distributed throughout the scaffolds. This multiphoton microscopy technique could be used to assess biomaterial delivery systems that can improve exogenous MSC presence and survival, facilitate endogenous cell infiltration, and investigate exogenous-endogenous cell interactions for bone regeneration therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.